Advances and prospects of drug clinical research in colorectal cancer in 2022
Abstract Colorectal cancer (CRC) is the third most common cancer and the second leading cause of cancer death worldwide. Clinical research results have provided more treatment opportunities for CRC patients, showing that an optimal combination of existing drugs and new drugs is needed to mitigate th...
Main Authors: | Dan Su, Chao Liu, Jie Cui, Jiebing Tang, Yuli Ruan, Yanqiao Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-04-01
|
Series: | Cancer Innovation |
Subjects: | |
Online Access: | https://doi.org/10.1002/cai2.62 |
Similar Items
-
Advances in medical treatment of breast cancer in 2022
by: Jingtong Zhai, et al.
Published: (2023-02-01) -
Pharmacoeconomic evaluation of the use of targeted therapy and chemotherapy in the first- and second-line therapies for metastatic colorectal cancer
by: A. A. Tryakin, et al.
Published: (2018-11-01) -
TWO PROGRAMS OF CHEMOTHERAPY IN COMBINATION WITH BEVACIZUMAB IN THE TREATMENT OF DISSEMINATED COLORECTAL CANCER
by: O. V. Zharkova, et al.
Published: (2015-02-01) -
Personalised neoantigen‐based therapy in colorectal cancer
by: Ya‐Juan Zhu, et al.
Published: (2023-11-01) -
Research Status and Progress on Treatment of Advanced Gastric Cancer
by: DONG Caixia, et al.
Published: (2022-11-01)